Rights and permissions
About this article
Cite this article
Extra cost of captopril justified in diabetic nephropathy. Pharmacoecon. Outcomes News 121, 6 (1997). https://doi.org/10.1007/BF03271802
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271802